Non-Hodgkin Lymphoma News
- FDA Panel Urges Acrotech to Speed Up Study on Cancer Drugs
- FDA Panel Voices Concerns Over Two Lymphoma Rushed Approvals
- SITC 2023 T-Cell Cancers: CAR T Therapy to the Rescue?
- ESMO 2023 PD-1 Inhibitor Improves Outcomes in NHL Subtype
- Dupilumab-Associated Lymphoid Reactions Require Caution
- ESMO 2023 Ocular MALT Lymphoma: Radiation Reduces Relapse
- ESMO 2023 ALK Inhibitor Alectinib Shows DFS Benefit in Early NSCLC
- ESMO 2023 Remote Symptom Monitoring in Advanced Cancer Improves QoL
- ASTRO 2023 When to Treat DLBCL With Radiotherapy?
- Survival on the Upswing in Multiple Myeloma
- ASTRO 2023 Salvage Option to Replace Transplant in RR Hodgkin Lymphoma?
- ADC Toxicities: The Price You Pay for Efficacy
- SOHO 2023 Safely Skip PET2 After Brentuximab in Hodgkin Lymphoma?
- 'Promising' New Txs for Most Common Adult Leukemia
- Atorvastatin Reduces Anthracycline-Associated Cardiotoxicity
- CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease
- Lymphoma Specialist to Lead MD Anderson’s Cancer Division
- Oral Cancer Drugs Requiring Prior Authorization on the Rise
- Do Some Randomized Controlled Trials Stack the Deck?
- Indian Health Service Dermatologist Saw a Need to Serve
- New Trials in Leukemia and Lymphoma Enrolling Now